Works by Yorioka, N

Results: 17

Screening for gastroenterological malignancies in new and maintenance dialysis patients.

Published in:

1999

By:

Ito, Takafumi;
Tanaka, Issei;
Kadoya, Takayuki;
Kimura, Mari;
Ooshiro, Takafumi;
Ooishi, Kouichi;
Tanaka, Junko;
Yorioka, Noriaki;
Ito, T;
Tanaka, I;
Kadoya, T;
Kimura, M;
Ooshiro, T;
Ooishi, K;
Tanaka, J;
Yorioka, N

Publication type:

journal article

Low-Density Lipoprotein Apheresis for Focal Glomerular Sclerosis.

Published in:

Therapeutic Apheresis & Dialysis, 1997, v. 1, n. 4, p. 370, doi. 10.1111/j.1744-9987.1997.tb00058.x

By:

Yorioka, N.;
Taniguchi, Y.;
Nishida, Y.;
Okushin, S.;
Amimoto, D.;
Yamakido, M.

Publication type:

Article

HMG-CoA reductase inhibitors prevent bone loss in patients with Type 2 diabetes mellitus.

Published in:

2004

By:

Nakashima A;
Nakashima R;
Ito T;
Masaki T;
Yorioka N

Publication type:

Journal Article

HMG-CoA reductase inhibitors prevent bone loss in patients with Type 2 diabetes mellitus.

Published in:

Diabetic Medicine, 2004, v. 21, n. 9, p. 1020, doi. 10.1111/j.1464-5491.2004.01292.x

By:

Nakashima, A.;
Nakashima, R.;
Ito, T.;
Masaki, T.;
Yorioka, N.

Publication type:

Article

Pharmacotherapy.

Published in:

1998

By:

Yorioka, Gerald N.;
Hogan, Robert

Publication type:

Product Review

Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy.

Published in:

2000

By:

Tomino, Yasuhiko;
Suzuki, Shigenobu;
Imai, Hirokazu;
Saito, Takao;
Kawamura, Tetsuya;
Yorioka, Noriaki;
Harada, Takashi;
Yasumoto, Yuichiro;
Kida, Hiroshi;
Kobayashi, Yutaka;
Endoh, Masayuki;
Sato, Hidetoshi;
Saito, Kensuke;
Tomino, Y;
Suzuki, S;
Imai, H;
Saito, T;
Kawamura, T;
Yorioka, N;
Harada, T

Publication type:

journal article

Dose conversion ratio one year after switching from epoetin alpha to darbepoetin alpha in Japanese hemodialysis patients.

Published in:

2010

By:

Hirai T;
Nakashima A;
Shiraki N;
Takasugi N;
Yorioka N;
Hirai, Takayuki;
Nakashima, Ayumu;
Shiraki, Nobuaki;
Takasugi, Norihisa;
Yorioka, Noriaki

Publication type:

journal article

Effects of dialysis membranes on the kinetics of tumor necrosis factor-alpha production by peripheral mononuclear cells in chronic hemodialysis patients.

Published in:

1998

By:

Kushihata, S;
Yorioka, N;
Oda, H;
Ye, X F;
Yamakido, M

Publication type:

journal article

PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation.

Published in:

Clinical & Experimental Immunology, 2006, v. 144, n. 2, p. 353, doi. 10.1111/j.1365-2249.2006.03073.x

By:

Hirai, T.;
Masaki, T.;
Kuratsune, M.;
Yorioka, N.;
Kohno, N.

Publication type:

Article

Chronic rheumatoid arthritis complicated by myeloperoxidase antineutrophil cytoplasmic antibody-associated nephritis.

Published in:

1999

By:

Yorioka, Noriaki;
Taniguchi, Yoshihiko;
Amimoto, Dai;
Miyata, Hideki;
Yamakido, Michio;
Taguchi, Takashi;
Yorioka, N;
Taniguchi, Y;
Amimoto, D;
Miyata, H;
Yamakido, M;
Taguchi, T

Publication type:

journal article

Localization of hepatocyte growth factor and tubulointerstitial lesions in IgA nephropathy.

Published in:

1997

By:

Taniguchi, Yoshihiko;
Yorioka, Noriaki;
Yamashita, Kazuomi;
Xue-Feng, Ye;
Nishiki, Tomoko;
Ogawa, Takahiko;
Oda, Hiroaki;
Yamakido, Michio;
Taniguchi, Y;
Yorioka, N;
Yamashita, K;
Xue-Feng, Y;
Nishiki, T;
Ogawa, T;
Oda, H;
Yamakido, M

Publication type:

journal article

Serum soluble interleukin-2 receptor in patients with glomerulonephritis.

Published in:

1990

By:

Yorioka, Noriaki;
Hirabayashi, Akira;
Kanahara, Koji;
Takemasa, Atsuo;
Oda, Hiroaki;
Hossain Joarder, Zahid;
Yamakido, Michio;
Yorioka, N;
Hirabayashi, A;
Kanahara, K;
Takemasa, A;
Oda, H;
Joarder, Z H;
Yamakido, M

Publication type:

journal article

Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients.

Published in:

Osteoporosis International, 2011, v. 22, n. 6, p. 1695, doi. 10.1007/s00198-010-1377-0

By:

Nakashima, A.;
Carrero, J. J.;
Qureshi, A. R.;
Hirai, T.;
Takasugi, N.;
Ueno, T.;
Taniguchi, Y.;
Lindholm, B.;
Yorioka, N.

Publication type:

Article

Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout life.

Published in:

Osteoporosis International, 2011, v. 22, n. 5, p. 1573, doi. 10.1007/s00198-010-1350-y

By:

Sugiya, N.;
Nakashima, A.;
Takasugi, N.;
Kawai, A.;
Kiribayashi, K.;
Tanaka, J.;
Kohno, N.;
Yorioka, N.

Publication type:

Article

Osteoprotegerin and bone mineral density in hemodialysis patients: reply to letter by Ulivieri et al.

Published in:

2006

By:

Nakashima, A.;
Yorioka, N.

Publication type:

Letter

Osteoprotegerin and bone mineral density in hemodialysis patients.

Published in:

Osteoporosis International, 2006, v. 17, n. 6, p. 841, doi. 10.1007/s00198-005-0047-0

By:

Nakashima, A.;
Yorioka, N.;
Doi, S.;
Takasugi, N.;
Shigemoto, K.;
Kohno, N.

Publication type:

Article

Alarm Bells in Medicine: Danger Symptoms in Medicine, Surgery, and Clinical Specialties.

Published in:

2006

By:

Yorioka, Gerald N.

Publication type:

Book Review